Biotricity announced it received 510(k) clearance from the FDA for its three-lead device for ECG and arrhythmia monitoring for use among lower risk patients. “Biotres is a Holter for low-risk patients and is designed for comfort for long-term wear,” Waqaas Al-Siddiq, founder and CEO of Biotricity, said in a press release from the company. “Cardiac disease […]

What You Should Know: – Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three-lead device for ECG and arrhythmia monitoring that is intended for lower-risk patients. – Most remote cardiac monitors are passive […]

Biotricity, a California-based healthcare technology company, has received FDA clearance for its new three-lead electrocardiogram (ECG) and arrhythmia monitoring solution. The Biotres Cardiac Monitoring Device was built to help monitor the cardiac health of low-risk patients. It includes Bluetooth connectivity, a rechargeable battery and an adjustable design that can be updated in the future as […]